Fusion Pharmaceuticals Inc. Deferred Revenue (Non-Current)
Fusion Pharmaceuticals Inc. had Deferred Revenue (Non-Current) of $667.00 thousand as of 2024-03-31, per its 10-Q filed 2024-05-07.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredRevenueNoncurrent · last filed 2024-05-07
- 2024-03-31: Deferred Revenue, Noncurrent $667.00K.
- 2023-12-31: Deferred Revenue, Noncurrent $667.00K.
- 2023-09-30: Deferred Revenue, Noncurrent $667.00K.
- 2023-06-30: Deferred Revenue, Noncurrent $2.67M.
| Period end | Deferred Revenue, Noncurrent |
|---|---|
| 2024-03-31 | $667.00K 10-Q · filed 2024-05-07 |
| 2023-12-31 | $667.00K 10-Q · filed 2024-05-07 |
| 2023-09-30 | $667.00K 10-Q · filed 2023-11-07 |
| 2023-06-30 | $2.67M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $2.67M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $2.67M 10-K · filed 2024-03-20 |
| 2022-09-30 | $2.67M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $2.50M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $2.50M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $2.50M 10-K · filed 2023-03-16 |
| 2021-09-30 | $2.17M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $2.87M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $4.00M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $4.00M 10-K · filed 2022-03-17 |